Items where authors include "Heymann, D."
Up a levelArticle
Panez-Toro, I., Heymann, D. orcid.org/0000-0001-7777-0669, Gouin, F. et al. (3 more authors) (2023) Roles of inflammatory cell infiltrate in periprosthetic osteolysis. Frontiers in Immunology, 14. 1310262. ISSN 1664-3224
Jubelin, C., Muñoz-Garcia, J., Cochonneau, D. et al. (5 more authors) (2023) Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements. Frontiers in Bioengineering and Biotechnology, 11. 1260049. ISSN 2296-4185
Panez-Toro, I. orcid.org/0000-0002-0060-7502, Muñoz-García, J. orcid.org/0000-0002-2978-1192, Vargas-Franco, J.W. et al. (4 more authors) (2023) Advances in osteosarcoma. Current Osteoporosis Reports, 21 (4). pp. 330-343. ISSN 1544-1873
Jubelin, C., Muñoz-Garcia, J., Griscom, L. et al. (6 more authors) (2022) Three-dimensional in vitro culture models in oncology research. Cell & Bioscience, 12 (1). 155. ISSN 2045-3701
Ollivier, L., Orione, C., Bore, P. et al. (18 more authors) (2022) Abscopal response in metastatic melanoma: real-world data of a retrospective, multicenter study. Cancers, 14 (17). 4213. ISSN 2072-6694
Muñoz-Garcia, J., Vargas-Franco, J.W., Royer, B.B.-L. et al. (5 more authors) (2022) Inhibiting endothelin receptors with macitentan strengthens the bone protective action of RANKL inhibition and reduces metastatic dissemination in osteosarcoma. Cancers, 14 (7). 1765. ISSN 2072-6694
Jubelin, C., Muñoz-Garcia, J., Cochonneau, D. et al. (3 more authors) (2022) Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma. Cancer Drug Resistance, 5 (1). pp. 184-198. ISSN 2578-532X
Tattersall, L. orcid.org/0000-0001-8835-0627, Shah, K.M. orcid.org/0000-0001-9909-6409, Lath, D.L. et al. (11 more authors) (2021) The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties. Journal of Bone Oncology, 31. 100398.
Grünewald, T.G.P., Alonso, M., Avnet, S. et al. (39 more authors) (2020) Sarcoma treatment in the era of molecular medicine. EMBO Molecular Medicine, 12 (11). e11131. ISSN 1757-4676
Moukengue, B., Brown, H.K., Charrier, C. et al. (11 more authors) (2020) TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model. EBioMedicine, 53. 102704. ISSN 2352-3964
Marino, S., de Ridder, D., Bishop, R.T. et al. (14 more authors) (2019) Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice. EBioMedicine, 44. pp. 452-466. ISSN 2352-3964
Chalopin, A., Tellez-Gabriel, M., Brown, H.K. et al. (4 more authors) (2018) Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy. Journal of Bone Oncology, 12. pp. 83-90. ISSN 2212-1374
de Ridder, D., Marino, S., Bishop, R.T. et al. (4 more authors) (2018) Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A. Scientific Reports , 8. 6877. ISSN 2045-2322
Brown, H.K., Schiavone, K., Gouin, F. et al. (2 more authors) (2018) Biology of bone sarcomas and new therapeutic developments. Calcified Tissue International, 102 (2). pp. 174-195. ISSN 0171-967X
Talbot, J., Brion, R., Lamora, A. et al. (4 more authors) (2018) Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts. Journal of Cellular Physiology, 233 (2). pp. 946-957. ISSN 0021-9541
Crenn, V., Biteau, K., Amiaud, J. et al. (8 more authors) (2017) Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy : retrospective analysis and preclinical modeling. American Journal of Cancer Research, 7 (11). pp. 2333-2349.
Benslimane-Ahmim, Z., Pereira, J., Lokajczyk, A. et al. (5 more authors) (2017) Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization. Cancer Letters, 395. pp. 11-19. ISSN 0304-3835
Brown, H.K., Schiavone, K., Tazzyman, S. et al. (2 more authors) (2017) Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opinion on Drug Discovery, 12 (4). pp. 379-389. ISSN 1746-0441
Tellez-Gabriel, M., Charrier, C., Brounais-Le Royer, B. et al. (4 more authors) (2017) Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchip. European Journal of Cell Biology, 96 (2). pp. 110-118. ISSN 0171-9335
Aubin, G.G., Baud'huin, M., Lavigne, J.P. et al. (7 more authors) (2017) Interaction of Cutibacterium (formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development. Scientific Reports, 7. 42918. ISSN 2045-2322
Heymann, D. orcid.org/0000-0001-7777-0669, Brown, H.K. and Tellez-Gabriel, M. (2017) Cancer Stem Cells in Osteosarcoma. Cancer Letters, 386. pp. 189-195. ISSN 0304-3835
Chemel, M., Brion, R., Segaliny, A.I. et al. (7 more authors) (2017) Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts. American Journal of Pathology, 187 (1). pp. 156-162. ISSN 0002-9440
Tellez-Gabriel, M., Ory, B., Lamoureux, F. et al. (2 more authors) (2016) Tumour heterogeneity: the key advantages of single-cell analysis. International Journal of Molecular Sciences, 17 (12). 2142. ISSN 1661-6596
De Seta, D., Mancini, P., Russo, F.Y. et al. (8 more authors) (2016) 3D curved multiplanar cone beam CT reconstruction for intracochlear position assessment of straight electrodes array. A temporal bones and patients study. Acta Otorhinolaryngologica Italica, 36 (6). pp. 499-505. ISSN 0392-100X
Heymann, D. orcid.org/0000-0001-7777-0669, Hochant, M., Pecqueur, C. et al. (9 more authors) (2016) Low-dose pesticide mixture induces senescence in normal mesenchymal stem cells (MSC) and promotes tumorigenic phenotype in premalignant MSC. Stem Cell. ISSN 1066-5099
De Sata , D., Torres , R., Russo, F.Y. et al. (7 more authors) (2016) Damage to inner ear structure during cochlear implantation: Correlation between insertion force and radio-histological findings in temporal bone specimens. Hearing Research. ISSN 0378-5955
Brulefert, K., Córdova, L.A., Brulin, B. et al. (7 more authors) (2016) Pro-osteoclastic In Vitro Effect of Polyethylene-like Nanoparticles: Involvement in the Pathogenesis of Implant Aseptic Loosening. Journal of Biomedical Research Part A, 104 (11). pp. 2649-2657. ISSN 1549-3296
Camuzard, O., Santucci-Darmanin, S., Breuil, V. et al. (9 more authors) (2016) Sex-specific autophagy modulation in osteoblastic lineage: a critical function to counteract bone loss in female. Oncotarget. ISSN 1949-2553
Tellez-Gabriel, M., Brown, H.K., Young, R. et al. (2 more authors) (2016) The Challenges of Detecting Circulating Tumor Cells in Sarcoma. Frontiers in Oncology, 6. 222. ISSN 2234-943X
Cordova, L.A., Guilbaud, F., Amiaud, J. et al. (6 more authors) (2016) Severe Compromise of Preosteoblasts in a Surgical Mouse Model of Bisphosphonate-Associated Osteonecrosis of the Jaw. Journal of Craniomaxillofacial Surgery, 44 (9). pp. 1387-1394. ISSN 1010-5182
Guiho, R., Biteau, K., Grisendi, G. et al. (6 more authors) (2016) TRAIL Delivered by Mesenchymal Stromal/Stem Cells Counteracts Tumor Development in Orthotopic Ewing Sarcoma Models. International Journal of Cancer. ISSN 0020-7136
Heymann, D., Renema, N., Navet, B. et al. (2 more authors) (2016) RANK-RANKL signalling in cancers. Bioscience Reports, 36 (4). e00366. ISSN 1573-4935
Chemel-Mary, M., Legoff, B., Maugars, Y. et al. (3 more authors) (2016) FRI0020 BMP-2 and TGF-B Inhibit IL-34 Expression in Rheumatoid Arthritis Synovial Fibroblasts. Annals of the Rheumatic Diseases, 75 (Suppl 2). pp. 432-433. ISSN 0003-4967
Rodriguez Calleja, L., Jacques, C., Lamoureux, F. et al. (13 more authors) (2016) ΔNp63α silences a microRNA program to aberrantly initiate a wound healing program that promotes TGFβ-induced metastasis. Cancer Research, 76 (11). pp. 3236-3251. ISSN 0008-5472
Ory, B., Baud'huin, M.E., Verrecchia, F. et al. (7 more authors) (2016) Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression. Clinical Cancer Research, 22 (10). pp. 2520-2533. ISSN 1078-0432
Jacques, C., Lamoureux, F., Baud'huin, M. et al. (8 more authors) (2016) Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1. Oncotarget. ISSN 1949-2553
Heymann, D. orcid.org/0000-0001-7777-0669, Ruiz-Velasco, C., Chesneau, J. et al. (3 more authors) (2016) Anti-Metastatic Properties of a Marine Bacterial Exopolysaccharide-Based Derivative Designed to Mimic Glycosaminoglycans. Molecules, 21 (3). 309. ISSN 1420-3049
Avril, P., Le Nail, L.R., Brennan, M.Á. et al. (6 more authors) (2016) Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status. Journal of Bone Oncology, 5 (1). pp. 5-14. ISSN 2212-1366
Gabriel, M.T., Calleja, L.R., Chalopin, A. et al. (2 more authors) (2016) Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. Clinical Chemistry, 62 (4). pp. 571-581. ISSN 0009-9147
Davaine, J-M., Quillard, T., Chatelais, M. et al. (7 more authors) (2016) Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. European Journal of Vascular and Endovascular Surgery, 51 (2). pp. 259-267. ISSN 1078-5884
Dumars, C., Nguyen, J.M., Gaultier, A. et al. (5 more authors) (2016) Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget, 7. pp. 78343-78354. ISSN 0032-0889
Jacques , C., Rodriguez-Calleja, L., Baud'huin, M. et al. (4 more authors) (2016) miRNA-193a-5p of p73 controls cisplatin chemoresistance in primary bone tumors. Oncotarget, 7. pp. 54503-54514. ISSN 1949-2553
Redini, F. and Heymann, D. orcid.org/0000-0001-7777-0669 (2015) Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma. Frontiers in Oncology, 5. 279. pp. 1-11. ISSN 2234-943X
Faucon, A., Benhelli-Mokrani, H., Cordova, L.A. et al. (5 more authors) (2015) Are Fluorescent Organic Nanoparticles Relevant Tools for Tracking Cancer Cells or Macrophages? Advanced Healthcare Materials, 4 (17). pp. 2727-2734. ISSN 2192-2640
Segaliny, A.I., Brion, R., Brulin, B. et al. (4 more authors) (2015) IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization. Cytokine, 76 (2). pp. 170-181. ISSN 1043-4666
Cremet, L., Broquet, A., Brulin, B. et al. (7 more authors) (2015) Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells. Pathogens and Disease, 73 (8). ftv065. ISSN 2049-632X
Heymann, D. orcid.org/0000-0001-7777-0669 (2015) Zoledronic acid. Encyclopedia of Cancer.
Heymann, D. orcid.org/0000-0001-7777-0669, Heymann, M.F. and Brown, H.K. (2015) Drugs in early clinical development for the treatment of osteosarcoma. Expert Opinion on Investigational Drugs. ISSN 1354-3784
Sousa, S., Brion, R., Lintunen, M. et al. (9 more authors) (2015) Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Research, 17. 101. ISSN 1465-5411
Ségaliny, A.I., Mohamadi, A., Dizier, B. et al. (7 more authors) (2015) Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. International Journal of Cancer , 137 (1). pp. 73-85. ISSN 0020-7136
Beranger, G.E., Djedaini, M., Battaglia, S. et al. (5 more authors) (2015) Oxytocin reverses osteoporosis in a sex-dependent manner. Frontiers in Endocrinology, 6. 81.
Lamora, A., Mullard, M., Amiaud, J. et al. (4 more authors) (2015) Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases. Oncotarget, 6 (16). pp. 14413-14427. ISSN 1949-2553
Segaliny, A.I., Brion, R., Mortier, E. et al. (5 more authors) (2015) Syndecan-1 regulates the biological activities of interleukin-34. BBA - Molecular Cell Research , 1853 (5). pp. 1010-1021. ISSN 0167-4889
Heymann, M-F., Renema, N. and Heymann, D. orcid.org/0000-0001-7777-0669 (2015) Alpelisib. Phosphatidylinositol 3-kinase alpha (PI3K alpha) inhibitor Oncolytic. Drugs of the Future, 40 (4). pp. 213-223. ISSN 0377-8282
Lezot, F., Chesneau, J., Navet, B. et al. (9 more authors) (2015) Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid. BONE, 73. pp. 51-59. ISSN 8756-3282
Guihard, P., Boutet, M-A., Royer, BB-L. et al. (8 more authors) (2015) Oncostatin M, an Inflammatory Cytokine Produced by Macrophages, Supports Intramembranous Bone Healing in a Mouse Model of Tibia Injury. American Journal of Pathology, 185 (3). pp. 765-775. ISSN 0002-9440
Segaliny, A.I., Tellez-Gabriel, M., Heymann, M-F. et al. (1 more author) (2015) Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. JOURNAL OF BONE ONCOLOGY, 4 (1). pp. 1-12. ISSN 2212-1374
Gobin, B., Baud'Huin, M., Lamoureux, F. et al. (8 more authors) (2015) BYL719, a new alpha-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. International Journal of Cancer, 136 (4). pp. 784-796. ISSN 0020-7136
Cordova, L.A., Trichet, V., Escriou, V. et al. (10 more authors) (2015) Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomaterialia, 13. pp. 150-158. ISSN 1742-7061
Guiho, R., Biteau, K., Heymann, D. orcid.org/0000-0001-7777-0669 et al. (1 more author) (2015) TRAIL-based therapy in pediatric bone tumors: how to overcome resistance. Future Oncology, 11 (3). pp. 535-542. ISSN 1479-6694
Gamblin, A-L., Brennan, M.A., Renaud, A. et al. (5 more authors) (2014) Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: The local implication of osteoclasts and macrophages. Biomaterials, 35 (36). pp. 9660-9667. ISSN 0142-9612
Gamblin, A.L., Renaud, A., Charrier, C. et al. (5 more authors) (2014) Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granules. Acta Biomaterialia, 10 (12). pp. 5139-5147. ISSN 1742-7061
Darrieutort-Laffite, C., Boutet, M-A., Chatelais, M. et al. (4 more authors) (2014) IL-1 beta and TNF alpha Promote Monocyte Viability through the Induction of GM-CSF Expression by Rheumatoid Arthritis Synovial Fibroblasts. Mediators of Inflammation, 2014. 241840. ISSN 0962-9351
Nollet, M., Santucci-Darmanin, S., Breuil, V. et al. (19 more authors) (2014) Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy, 10 (11). pp. 1965-1977. ISSN 1554-8627
Lezot, F., Chesneau, J., Battaglia, S. et al. (5 more authors) (2014) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. BONE, 68. pp. 146-152. ISSN 8756-3282
Brennan, M.A., Renaud, A., Amiaud, J. et al. (5 more authors) (2014) Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate. Stem Cell Research & Therapy, 5. 114. ISSN 1757-6512
Lamora, A., Talbot, J., Bougras, G. et al. (10 more authors) (2014) Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma. Clinical Cancer Research, 20 (19). pp. 5097-5112. ISSN 1078-0432
Davaine, J-M., Quillard, T., Brion, R. et al. (10 more authors) (2014) Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability. PLoS ONE, 9 (9). e107642. ISSN 1932-6203
Cordova, L.A., Stresing, V., Gobin, B. et al. (6 more authors) (2014) Orthopaedic implant failure: aseptic implant loosening--the contribution and future challenges of mouse models in translational research. Clinical Science, 127 (5). pp. 277-293. ISSN 0143-5221
Lau, A., Sun, J., Hannah, W. et al. (4 more authors) (2014) Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia, 20 (5). pp. 716-722. ISSN 1351-8216
Lamoureux, F., Baud'huin, M., Ory, B. et al. (5 more authors) (2014) Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma. Oncotarget, 5 (17). pp. 7805-7819. ISSN 1949-2553
Teletchea, S., Stresing, V., Hervouet, S. et al. (6 more authors) (2014) Novel RANK Antagonists for the Treatment of Bone-Resorptive Disease: Theoretical Predictions and Experimental Validation. Journal of Bone and Mineral Research, 29 (6). pp. 1466-1477. ISSN 0884-0431
Rousseau, J., Gioia, R., Layrolle, P. et al. (6 more authors) (2014) Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. European Journal of Human Genetics, 22 (5). pp. 667-674. ISSN 1018-4813
Beranger, G.E., Pisani, D.F., Castel, J. et al. (9 more authors) (2014) Oxytocin Reverses Ovariectomy-Induced Osteopenia and Body Fat Gain. Endocrinology, 155 (4). pp. 1340-1352. ISSN 0013-7227
Gobin, B., Battaglia, S., Lanel, R. et al. (5 more authors) (2014) NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate. Cancer Letters, 344 (2). pp. 291-298. ISSN 0304-3835
Odri, G., Kim, P-P., Lamoureux, F. et al. (6 more authors) (2014) Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration. BMC Cancer, 14. 169. ISSN 1471-2407
Gobin, B., Moriceau, G., Ory, B. et al. (5 more authors) (2014) Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models. PLoS ONE, 9 (3). e90795. ISSN 1932-6203
Lamoureux, F., Baud'huin, M., Calleja, L.R. et al. (7 more authors) (2014) Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. NATURE COMMUNICATIONS, 5. ARTN 3511. ISSN 2041-1723
Le Goff, B., Berthelot, J-M., Maugars, Y. et al. (1 more author) (2013) Osteoclasts in RA: Diverse origins and functions. Joint Bone Spine, 80 (6). pp. 586-591. ISSN 1297-319X
Monderer, D., Luseau, A., Bellec, A. et al. (14 more authors) (2013) New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Laboratory Investigation, 93 (10). pp. 1100-1114. ISSN 0023-6837
Baud'huin, M.E., Duplomb, L., Teletchea, S. et al. (6 more authors) (2013) Osteoprotegerin: multiple partners for multiple functions. Cytokine and Growth Factor Reviews, 24 (5). pp. 401-409. ISSN 1359-6101
Redini, F., Odri, G.A., Picarda, G. et al. (4 more authors) (2013) Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? Expert Opinion on Emerging Drugs, 18 (3). pp. 339-352. ISSN 1472-8214
Picarda, G., Matous, E., Amiaud, J. et al. (8 more authors) (2013) Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL. Journal of Bone Oncology, 2 (3). pp. 95-104. ISSN 2212-1374
Deschaseaux, F., Gaillard, J., Langonne, A. et al. (8 more authors) (2013) Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. FASEB Journal, 27 (8). pp. 2977-2987. ISSN 0892-6638
Benslimane-Ahmim, Z., Poirier, F., Delomenie, C. et al. (8 more authors) (2013) Mechanistic study of the proangiogenic effect of osteoprotegerin. Angiogenesis, 16 (3). pp. 575-593. ISSN 0969-6970
Georges, S., Chesneau, J., Hervouet, S. et al. (7 more authors) (2013) A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis. European Journal of Cancer, 49 (9). pp. 2253-2263. ISSN 0959-8049
Ando, K., Heymann, M.F., Stresing, V. et al. (3 more authors) (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers, 5 (2). pp. 591-616. ISSN 2072-6694
Miot-Noirault, E., David, E., Vidal, A. et al. (8 more authors) (2013) Tc-99m-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model. EJNMMI Research, 3. 40. ISSN 2191-219X
Talbot, J., Brion, R., Picarda, G. et al. (8 more authors) (2013) Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832 (4). pp. 553-564. ISSN 0925-4439
Heymann, D. orcid.org/0000-0001-7777-0669 and Rédini, F. (2013) Targeted therapies for bone sarcomas. BoneKEy Reports, 2. 378. ISSN 2047-6396
Bouacida, A., Rosset, P., Trichet, V. et al. (7 more authors) (2012) Pericyte-Like Progenitors Show High Immaturity and Engraftment Potential as Compared with Mesenchymal Stem Cells. PLoS ONE, 7 (11). e48648. ISSN 1932-6203
David, E., Tirode, F., Baud'huin, M. et al. (7 more authors) (2012) Oncostatin M Is a Growth Factor for Ewing Sarcoma. The American Journal of Pathology, 181 (5). pp. 1782-1795. ISSN 0002-9440
Peyrode, C., Weber, V., David, E. et al. (10 more authors) (2012) Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies. Investigational New Drugs, 30 (4). pp. 1782-1790. ISSN 0167-6997
Heymann, D. orcid.org/0000-0001-7777-0669 (2012) Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences. Journal of Bone Oncology, 1 (1). pp. 2-11. ISSN 2212-1366
Heymann, M-F., Herisson, F., Davaine, J-M. et al. (6 more authors) (2012) Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds. Cytokine, 58 (2). pp. 300-306. ISSN 1043-4666
Guihard, P., Danger, Y., Brounais, B. et al. (9 more authors) (2012) Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling. Stem Cells, 30 (4). pp. 762-772. ISSN 1066-5099
Anjubault, T., Martin, J., Hubert, F-X. et al. (3 more authors) (2012) Constitutive Expression of TNF-Related Activation-Induced Cytokine (TRANCE)/Receptor Activating NF-kappa B Ligand (RANK)-L by Rat Plasmacytoid Dendritic Cells. PLoS ONE, 7 (3). e33713. ISSN 1932-6203
Picarda, G., Surget, S., Guiho, R. et al. (7 more authors) (2012) A Functional, New Short Isoform of Death Receptor 4 in Ewing's Sarcoma Cell Lines May be Involved in TRAIL Sensitivity/Resistance Mechanisms. Molecular Cancer Research, 10 (3). pp. 336-346. ISSN 1541-7786
Moriceau, G., Roelofs, A.J., Brion, R. et al. (4 more authors) (2012) Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Cancer, 118 (3). pp. 750-760. ISSN 0008-543X
Chemel, M., Le Goff, B., Brion, R. et al. (10 more authors) (2012) Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Annals of the Rheumatic Diseases (ARD), 71 (1). pp. 150-154. ISSN 0003-4967
Ando, K., Mori, K., Verrecchia, F. et al. (3 more authors) (2012) Molecular Alterations Associated with Osteosarcoma Development. Sarcoma, 2012. 523432. ISSN 1357-714X
Baud'Huin, M., Charrier, C., Bougras, G. et al. (4 more authors) (2012) Proteoglycans and osteolysis. Proteoglycans, 836. pp. 323-337. ISSN 1064-3745
Picarda, G., Trichet, V., Teletchea, S. et al. (2 more authors) (2012) TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment. American Journal of Cancer Research, 2 (1). pp. 45-64. ISSN 2156-6976
Rousseau, J., Escriou, V., Lamoureux, F. et al. (8 more authors) (2011) Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models. Journal of Bone and Mineral Research, 26 (10). pp. 2452-2462. ISSN 0884-0431
Battaglia, S., Dumoucel, S., Chesneau, J. et al. (6 more authors) (2011) Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient. Journal of Bone and Mineral Research, 26 (10). pp. 2439-2451. ISSN 0884-0431
Heymann, D. orcid.org/0000-0001-7777-0669 and Rédini, F. (2011) Bone sarcomas: pathogenesis and new therapeutic approaches. IBMS BoneKEy, 8 (9). pp. 402-414. ISSN 1940-8692
Le Goff, B. and Heymann, D. orcid.org/0000-0001-7777-0669 (2011) Pharmacodynamics of bisphosphonates in arthritis. Expert Review of Clinical Pharmacology, 4 (5). pp. 633-641. ISSN 1751-2433
Herisson, F., Heymann, M-F., Chetiveaux, M. et al. (8 more authors) (2011) Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis, 216 (2). pp. 348-354. ISSN 0021-9150
Velasco, C.R., Baud'huin, M., Sinquin, C. et al. (4 more authors) (2011) Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology. Glycobiology, 21 (6). pp. 781-795. ISSN 0959-6658
Oliver, L., Hue, E., Rossignol, J. et al. (6 more authors) (2011) Distinct Roles of Bcl-2 and Bcl-Xl in the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells during Differentiation. PLoS ONE, 6 (5). e19820. ISSN 1932-6203
David, E., Guihard, P., Brounais, B. et al. (10 more authors) (2011) Direct anti-cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer, 128 (8). pp. 1822-1835. ISSN 0020-7136
Benslimane-Ahmim, Z., Heymann, D. orcid.org/0000-0001-7777-0669, Dizier, B. et al. (9 more authors) (2011) Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. Journal of Thrombosis and Haemostasis, 9 (4). pp. 834-843. ISSN 1538-7933
Ando, K., Mori, K., Corradini, N. et al. (2 more authors) (2011) Mifamurtide for the treatment of nonmetastatic osteosarcoma. Expert Opinion on Pharmacotherapy, 2 (12). pp. 285-292. ISSN 1465-6566
Saidi, S., Bouri, F., Lencel, P. et al. (9 more authors) (2011) IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine, 53 (3). pp. 347-354. ISSN 1043-4666
David, E., Blanchard, F., Heymann, M.F. et al. (4 more authors) (2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma, 2011. 932451. ISSN 1357-714X
Baud'huin, M., Ruiz-Velasco, C., Jego, G. et al. (9 more authors) (2011) Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption. European Journal of Cell Biology, 90 (1). pp. 49-57. ISSN 0171-9335
Baud'huin, M., Ruiz-Velasco, C., Jego, G. et al. (9 more authors) (2011) Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption. European Journal of Cell Biology, 90 (1). pp. 49-57. ISSN 0171-9335
Peyrode, C., Gouin, F., Vidal, A. et al. (8 more authors) (2011) A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model. Sarcoma, 2011. 691608. ISSN 1357-714X
Moriceau, G., Ory, B., Mitrofan, L. et al. (11 more authors) (2010) Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research, 70 (24). pp. 10329-10339. ISSN 0008-5472
Heymann, D. orcid.org/0000-0001-7777-0669 (2010) Interleukin-34: An enigmatic cytokine. IBMS BoneKEy, 7 (11). pp. 406-413. ISSN 1940-8692
Odri, G.A., Dumoucel, S., Picarda, G. et al. (10 more authors) (2010) Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research, 70 (19). pp. 7610-7619. ISSN 0008-5472
Isidor, B., Pichon, O., Redon, R. et al. (13 more authors) (2010) Mesomelia-Synostoses Syndrome Results from Deletion of SULF1 and SLCO5A1 Genes at 8q13. American Journal of Human Genetics, 87 (1). pp. 95-100. ISSN 0002-9297
Velasco, C.R., Colliec-Jouault, S., Redini, F. et al. (2 more authors) (2010) Proteoglycans on bone tumor development. Drug Discovery Today, 15 (13-14). pp. 553-560. ISSN 1359-6446
Perrot, P., Rousseau, J., Bouffaut, A-L. et al. (8 more authors) (2010) Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence. PLOS ONE, 5 (6). e10999. ISSN 1932-6203
Rousseau, J., Escriou, V., Perrot, P. et al. (6 more authors) (2010) Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Therapy , 17 (6). pp. 387-397. ISSN 0929-1903
Lezot, F., Thomas, B.L., Blin-Wakkach, C. et al. (8 more authors) (2010) Dlx Homeobox Gene Family Expression in Osteoclasts. Journal of Cellular Physiology, 223 (3). pp. 779-787. ISSN 0021-9541
Baud'Huin, M., Renault, R., Charrier, C. et al. (6 more authors) (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. Journal of Pathology, 221 (1). pp. 77-86. ISSN 0022-3417
Le Goff, B., Blanchard, F., Berthelot, J-M. et al. (2 more authors) (2010) Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine, 77 (3). pp. 201-205. ISSN 1297-319X
Picarda, G., Lamoureux, F., Geffroy, L. et al. (7 more authors) (2010) Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival. Clinical Cancer Research, 16 (8). pp. 2363-2374. ISSN 1078-0432
Heymann, D. orcid.org/0000-0001-7777-0669 (2010) Bisphosphonates and Bone Diseases: Past, Present and Future. Current Pharmaceutical Design, 16 (27). pp. 2948-2949. ISSN 1381-6128
Moriceau, G., Ory, B., Gobin, B. et al. (5 more authors) (2010) Therapeutic Approach of Primary Bone Tumours by Bisphosphonates. Current Pharmaceutical Design, 16 (27). pp. 2981-2987. ISSN 1381-6128
Le Goff, B., Soltner, E., Charrier, C. et al. (4 more authors) (2009) A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Research & Therapy, 11 (6). R185. ISSN 1478-6354
Baud'huin, M., Duplomb, L., Teletchea, S. et al. (4 more authors) (2009) Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival. The Journal of Biological Chemistry, 284 (46). pp. 31704-31713. ISSN 0021-9258
Deschaseaux, F., Sensebe, L. and Heymann, D. orcid.org/0000-0001-7777-0669 (2009) Mechanisms of bone repair and regeneration. Trends in Molecular Medicine , 15 (9). pp. 417-429. ISSN 1471-4914
Rossignol, J., Boyer, C., Thinard, R. et al. (12 more authors) (2009) Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. Journal of Cellular and Molecular Medicine, 13 (8B). pp. 2547-2558. ISSN 1582-1838
Brounais, B., David, E., Chipoy, C. et al. (8 more authors) (2009) Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone, 44 (5). pp. 830-839. ISSN 8756-3282
Georges, S., Veiasco, C.R., Trichet, V. et al. (3 more authors) (2009) Proteases and bone remodelling. Cytokine & Growth Factor Reviews, 20 (1). pp. 29-41. ISSN 1359-6101
Mori, K., Ando, K., Heymann, D. orcid.org/0000-0001-7777-0669 et al. (1 more author) (2009) Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells? Histology and Histopathology, 24 (2). pp. 235-242. ISSN 0213-3911
Lamoureux, F., Picarda, G., Garrigue-Antar, L. et al. (7 more authors) (2009) Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma. Cancer Research, 69 (2). pp. 526-536. ISSN 0008-5472
Chauvin, C., Philippeau, J-M., Hemont, C. et al. (7 more authors) (2008) Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats. Cancer Research, 68 (22). pp. 9433-9440. ISSN 0008-5472
Mori, K., Blanchard, F., Charrier, C. et al. (6 more authors) (2008) Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk. Cancer Science, 99 (11). pp. 2170-2176. ISSN 1347-9032
Brounais, B., Ruiz, C., Rousseau, J. et al. (4 more authors) (2008) Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption. Recent Patents on Anti-Cancer Drug Discovery, 3 (3). pp. 178-186. ISSN 1574-8928
Lamoureux, F., Picarda, G., Rousseau, J. et al. (6 more authors) (2008) Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Molecular Cancer Therapeutics, 7 (10). pp. 3389-3398. ISSN 1535-7163
Brounais, B., Chipoy, C., Mori, K. et al. (7 more authors) (2008) Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of midostaurin in vivo. Clinical Cancer Research, 14 (17). pp. 5400-5409. ISSN 1078-0432
Ando, K., Mori, K., Rédini, F. et al. (1 more author) (2008) RANKL/RANK/OPG: key therapeutic target in bone oncology. Current Drug Discovery Technologies, 5 (3). pp. 263-268. ISSN 1570-1638
Duplomb, L., Baud'huin, M., Charrier, C. et al. (4 more authors) (2008) Interleukin-6 inhibits receptor activator of nuclear factor kappa B ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: Key role of Serine(727) phosphorylation of signal transducer and activator of transcription 3. Endocrinology, 149 (7). pp. 3688-3697. ISSN 0013-7227
Heymann, M-F., Riet, A., Le Goff, B. et al. (3 more authors) (2008) OPG, RANK and RANK ligand expression in thyroid lesions. Regulatory Peptides, 148 (1-3). pp. 46-53. ISSN 0167-0115
Ory, B., Moriceau, G.D., Trichet, V. et al. (5 more authors) (2008) Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells. J Cell Mol Med, 12 (3). pp. 928-941. ISSN 1582-1838
Lamoureux, F., Ory, B., Battaglia, S. et al. (6 more authors) (2008) Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid. International Journal of Cancer, 122 (4). pp. 751-760. ISSN 0020-7136
Mori, K., Ando, K. and Heymann, D. orcid.org/0000-0001-7777-0669 (2008) Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases. Expert Review of Anticancer Therapy, 8 (2). pp. 151-159. ISSN 1473-7140
Mori, K., Berreur, M., Blanchard, F. et al. (5 more authors) (2007) Receptor activator of nuclear factor-kappa B ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. Oncology Reports, 18 (6). pp. 1365-1371. ISSN 1021-335X
Chipoy, C., Brounais, B., Trichet, V. et al. (7 more authors) (2007) Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene, 26 (46). pp. 6653-6664. ISSN 0950-9232
Baud'huin, M., Lamoureuxa, F., Duplomba, L. et al. (2 more authors) (2007) RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases. Cellular and Molecular Life Sciences, 64 (18). pp. 2334-2350. ISSN 1420-682X
Lamoureux, F., Richard, P., Wittrant, Y. et al. (8 more authors) (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: Blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Research, 67 (15). pp. 7308-7318. ISSN 0008-5472
Perrot, P., Heymann, D. orcid.org/0000-0001-7777-0669, Charrier, C. et al. (3 more authors) (2007) Extraosseous bone formation obtained by association of mesenchymal stem cells with a periosteal flap in the rat. Annals of Plastic Surgery, 59 (2). pp. 201-206. ISSN 0148-7043
Lamoureux, F., Baud'huin, M., Duplomb, L. et al. (2 more authors) (2007) Proteoglycans: key partners in bone cell biology. BioEssays, 29 (8). pp. 758-771. ISSN 0265-9247
Mori, K., Le Goff, B., Charrier, C. et al. (3 more authors) (2007) DU145 human prostate cancer cells express functional receptor activator of NF kappa B: New insights in the prostate cancer bone metastasis process. Bone , 40 (4). pp. 981-990. ISSN 8756-3282
Mori, K., Le Goff, B., Berreur, M. et al. (11 more authors) (2007) Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. The Journal of Pathology, 211 (5). pp. 555-562. ISSN 0022-3417
Duplomb, L., Dagouassat, M., Jourdon, P. et al. (1 more author) (2007) Concise review: Embryonic stem cells: A new tool to study osteoblast and osteoclast differentiation. Stem Cells, 25 (3). pp. 544-552. ISSN 1066-5099
Baud'huin, M., Duplomb, L., Velasco, C.R. et al. (3 more authors) (2007) Key roles of the OPG-RANK-RANKL system in bone oncology. Expert Review of Anticancer Therapy, 7 (2). pp. 221-232. ISSN 1473-7140
Duplomb, L., Dagouassat, M., Jourdon, P. et al. (1 more author) (2007) Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body. In Vitro Cellular & Developmental Biology - Animal, 43 (1). pp. 21-24. ISSN 1071-2690
Ory, B., Blanchard, F., Battaglia, S. et al. (3 more authors) (2007) Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. Molecular Pharmacology, 71 (1). pp. 333-343. ISSN 0026-895X
Ory, B., Moriceau, G., Redini, F. et al. (1 more author) (2007) mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: Bi-functional compounds for the treatment of bone tumours. Current Medicinal Chemistry, 14 (13). pp. 1381-1387. ISSN 0929-8673
Tat, S.K., Padrines, M., Theoleyre, S. et al. (4 more authors) (2006) OPG/membranous-RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation. Bone, 39 (4). pp. 706-715. ISSN 8756-3282
Gouin, F., Ory, B., Redini, F. et al. (1 more author) (2006) Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. International Journal of Cancer, 119 (5). pp. 980-984. ISSN 0020-7136
Theoleyre, S., Tat, S.K., Vusio, P. et al. (7 more authors) (2006) Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor kappa B ligand (RANKL) and RANK. Biochemical and Biophysical Research Communications, 347 (2). pp. 460-467. ISSN 0006-291X
Heymann, D. orcid.org/0000-0001-7777-0669 (2006) Autophagy: A protective mechanism in response to stress and inflammation. Current Opinion in Investigational Drugs, 7 (5). pp. 443-450. ISSN 1472-4472
Mori, K., Redini, F., Gouin, F. et al. (2 more authors) (2006) Osteosarcoma: Current status of immunotherapy and future trends (Review). Oncology Reports, 15 (3). pp. 693-700. ISSN 1021-335X
Wittrant, Y., Lamoureux, F., Mori, K. et al. (4 more authors) (2006) RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells. International Journal of Oncology, 28 (1). pp. 261-269. ISSN 1019-6439
Ory, B., Heymann, M.F., Kamijo, A. et al. (3 more authors) (2005) Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice. Cancer, 104 (11). pp. 2522-2529. ISSN 0008-543X
Theoleyre, S., Mori, K., Cherrier, B. et al. (4 more authors) (2005) Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma. BMC Cancer, 5. 123. ISSN 1471-2407
Heymann, D. orcid.org/0000-0001-7777-0669, Ory, B., Blanchard, F. et al. (7 more authors) (2005) Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone , 37 (1). pp. 74-86. ISSN 8756-3282
Heymann, D. orcid.org/0000-0001-7777-0669, Fortun, Y., Redini, F. et al. (1 more author) (2005) Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools. Drug Discovery Today, 10 (4). pp. 242-247. ISSN 1359-6446
Theoleyre, S., Wittrant, Y., Tat, S.K. et al. (3 more authors) (2004) The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine & Growth Factor Reviews, 15 (6). pp. 457-475. ISSN 1359-6101
Chipoy, C., Berreur, M., Couillaud, S. et al. (6 more authors) (2004) Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin m in osteosarcoma cells require PKC delta and STAT3. Journal of Bone and Mineral Research (JBMR), 19 (11). pp. 1850-1861. ISSN 0884-0431
Wittrant, Y., Theoleyre, S., Chipoy, C. et al. (4 more authors) (2004) RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1704 (2). pp. 49-57. ISSN 0304-419X
Heymann, D. orcid.org/0000-0001-7777-0669, Ory, B., Gouin, F. et al. (2 more authors) (2004) Bisphosphonates: new therapeutic agents for the treatment of bone tumors. Trends in Molecular Medicine, 10 (7). pp. 337-343. ISSN 1471-4914
Wittrant, Y., Theoleyre, S., Couillaud, S. et al. (3 more authors) (2004) Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kappa B ligand and osteoprotegerin biological activities. Experimental Cell Research, 293 (2). pp. 292-301. ISSN 0014-4827
Kwan Tat, S., Padrines, M., Théoleyre, S. et al. (2 more authors) (2004) IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine and Growth Factor Reviews, 15 (1). pp. 49-60. ISSN 1359-6101
Grimaud, E., Soubigou, L., Couillaud, S. et al. (6 more authors) (2003) Receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. The American Journal of Pathology, 163 (5). pp. 2021-2031. ISSN 0002-9440
Wittrant, Y., Theoleyre, S., Couillaud, S. et al. (3 more authors) (2003) Regulation of osteoclast protease expression by RANKL. Biochemical and Biophysical Research Communications, 310 (3). pp. 774-778. ISSN 0006-291X
Grimaud, E., Damiens, C., Rousselle, A.V. et al. (3 more authors) (2002) Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma. Histology and Histopathology, 17 (4). pp. 1103-1111. ISSN 0213-3911
Wittrant, Y., Couillaud, S., Theoleyre, S. et al. (3 more authors) (2002) Osteoprotegerin differentially regulates protease expression in osteoclast cultures. Biochemical and Biophysical Research Communications, 293 (1). pp. 38-44. ISSN 0006-291X
Heymann, D. orcid.org/0000-0001-7777-0669, Pradal, G. and Benahmed, M. (1999) Cellular mechanisms of calcium phosphate ceramic degradation. Histology and Histopathology , 14 (3). pp. 871-877. ISSN 0213-3911
Book Section
Heymann, D. orcid.org/0000-0001-7777-0669 and Heymann, M.F. (2018) Osteoprotegerin. In: Choi, S., (ed.) Encyclopedia of Signaling Molecules, 2nd Edition. Springer . ISBN 978-3-319-67198-7
Heymann, M.F. and Heymann, D. orcid.org/0000-0001-7777-0669 (2017) Immune environment and osteosarcoma. In: Honoki, K. and Weiss, K.R., (eds.) Osteosarcoma: Biology, behaviour and mechanisms. IntechOpen , pp. 105-120. ISBN 978-953-51-3096-3
Heymann, D. orcid.org/0000-0001-7777-0669 (2017) Zoledronic acid. In: Schwab, M., (ed.) Encyclopedia of Cancer. Springer-Verlag Berlin Heidelberg . ISBN 978-3-662-46874-6